Summary
To assess the pathophysiology of the sympathetic nervous system in familial amyloidotic polyneuropathy (FAP), we used3H-bunazosin to identify and characterize the alpha1-adrenergic receptor in human aortic membranes. The binding of3H-bunazosin was rapid, readily reversible, stereospecific, and saturable. The Scatchard analysis described a single class of binding sites with a dissociation constant (KD) of 0.370±0.035nM and a maximal binding capacity (Bmax) of 11.8±1.30 fmol/mg protein in control patients. Competition analysis demonstrated the alpha1-adrenergic specificity of the3H-bunazosin binding sites in human aortic membranes. The KD and Bmax of3H-bunazosin binding in four FAP patients was 0.274±0.052 nM and 7.79±0.15 fmol/mg protein, respectively; these values did not differ significantly from those in 14 control patients. An increase in Bmax or affinity of alpha1-adrenergic receptors may not be the cause for denervation supersensitivity in FAP.
Similar content being viewed by others
References
Azuma T, Suzuki T, Sakoda S, Higa S, Mizuno R, Kishimoto S, Ikeda S, Yanagisawa N, Uekawa K, Takaba Y, Nakajima A (1987) α2-Adrenergic receptor in familial amyloidotic polyneuropathy. J Neurol Sci 81: 281–286
Bolton TB (1979) Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59: 606–718
Cambridge D, Davey MJ, Massingham R (1977) Prazosin, a selective antagonist of post synaptic α-adrenoceptors. Br J Pharmacol 59: 514–515
Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (ki) and the concentration of inhibition which cause 50 percent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22: 3099–3108
Colucci WS, Gimbrone MA, Alexander RW (1981) Regulation of the postsynaptic α-adrenergic receptor in rat mesenteric artery. Circ Res 48: 104–111
Glenner GG, Ignaczak TF, Page DL (1978) The inherited systemic amyloidoses and localized amyloid deposits. In: Stanbury JB, Wyngaarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease, 4th edn. McGraw Hill, New York, pp 1308–1339
Goodhardt M, Ferry N, Geynet P, Hanoune J (1982) Hepatic α1-adrenergic receptors show agonist-specific regulation by guanine nucleotides, loss of nucleotide effect after adrenalectomy. J Biol Chem 257: 11577–11583
Hata F, Kondo E, Kondo S, Kagawa K (1982) Characteristics of (3H)E-643-binding to alpha adrenoceptors. Jpn J Pharmacol 32: 181–187
Ikeda S, Hanyu N, Yanagisawa N, Hongo M, Oguchi H, Ito N (1986) Clinical and pathological studies of familial amyloid polyneuropathy (FAP), with special reference to nephropathy and cardiopathy. In: Glenner GG, Osserman EF, Benditt EP, Calkins E, Cohen AS, Zucker-Franklin D (eds) Amyloidosis. Plenum Press, New York, pp 415–428
Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Michell RH (1975) Inositol phospholipids and cell surface receptor function. Biochim Biophys Acta 415: 81–147
Sakoda S, Suzuki T, Higa S, Ueji M, Kishimoto S, Hayashi A, Yasuda N, Takaba Y, Nakajima A (1983) Genetic studies of famlial amyloid polyneurophathy in the Arao district of Japan: 1. The genealogical survey. Clin Genet 24: 334–338
Starke K, Borowski E, Endo T (1975) Preferential blockade of presynaptic α-adrenoceptors by yohimbine. Eur J Pharmacol 34: 385–388
Suzuki T, Tsuge I, Higa S, Hayashi A, Yamamura Y, Takaba Y, Nakajima A (1979) Catecholamine metabolism in familial amyloid polyneuropathy. Clin Genet 16: 117–124
Suzuki T, Higa S, Tsuge I, Sakoda S, Hayashi A, Yamamura Y, Takaba Y, Nakajima A (1980) Effect of infused L-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy. Eur J Clin Pharmacol 17: 429–435
Suzuki T, Higa S, Sakoda S, Hayashi A, Yamamura Y, Takaba Y, Nakajima A (1981) Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxphenylserine. Neurology (NY) 31: 1323–1326
Williams LT, Mullikin D, Lefkowitz RJ (1976) Identification of α-adrenergic receptors in uterine smooth muscle membranes by3H-dihydroergocryptine binding. J Biol Chem 251: 6915–6923
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Azuma, T., Watanabe, Y., Suzuki, T. et al. The aortic alpha1-adrenergic receptor in familial amyloidotic polyneuropathy. J. Neural Transmission 73, 23–30 (1988). https://doi.org/10.1007/BF01244619
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01244619